Hana Jansova Selected Research

salicylaldehyde isonicotinoyl hydrazone

1/2014

Quantitative analysis of the anti-proliferative activity of combinations of selected iron-chelating agents and clinically used anti-neoplastic drugs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hana Jansova Research Topics

Disease

3	Cardiotoxicity 01/2019 - 01/2013
3	Neoplasms (Cancer) 12/2015 - 01/2013
1	Heart Failure 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2014

Drug/Important Bio-Agent (IBA)

3	AnthracyclinesIBA 01/2019 - 01/2013
2	Dexrazoxane (Zinecard)FDA LinkGeneric 12/2017 - 01/2013
2	di- 2- pyridylketone- 4,4- dimethyl- 3- thiosemicarbazoneIBA 12/2015 - 01/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014 - 01/2013
1	Proteasome InhibitorsIBA 01/2019
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019
1	JR-311IBA 12/2017
1	ThiosemicarbazonesIBA 12/2015
1	Deferoxamine (Desferal)FDA LinkGeneric 01/2014
1	Fluorouracil (Carac)FDA LinkGeneric 01/2014
1	HydrazonesIBA 01/2014
1	IronIBA 01/2014
1	Methotrexate (Mexate)FDA LinkGeneric 01/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2014
1	Estrogen ReceptorsIBA 01/2014
1	Tamoxifen FDA LinkGeneric 01/2014
1	perfosfamideIBA 01/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2014
1	SiderophoresIBA 01/2014
1	Chelating AgentsIBA 01/2014
1	salicylaldehyde isonicotinoyl hydrazoneIBA 01/2014
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2013
1	CaspasesIBA 01/2013
1	Cardiotonic Agents (Cardiac Stimulants)IBA 01/2013
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2013
1	Protein Isoforms (Isoforms)IBA 01/2013

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2014